Medication-assisted treatment (MAT) is the standard of care for incarcerated individuals with opioid use disorder. To reduce legal liability and provide high quality care to individuals in correctional facilities, administrative and health staff may begin exploring starting or expanding an MAT program. However, regulatory restrictions, lack of buy-in from leadership and staff, risk of diversion, and limited resources may pose serious barriers. This expert panel will provide a brief background on opioid use disorder and MAT in correctional environments, evidence in favor of MAT, and common barriers to the provision of FDA-approved buprenorphine, methadone, and naltrexone. During the remainder of the session, speakers will provide an opportunity for open discussion and Q&A regarding successful provision of MAT, overcoming common barriers, and OTP accreditation.

Educational Objectives

• Explore the use of MAT in corrections
• Describe common barriers to MAT implementation
• Discuss OTP accreditation

Level: Intermediate